Cutter & Co Brokerage’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-11,225
Closed -$270K 275
2017
Q2
$270K Hold
11,225
0.11% 193
2017
Q1
$222K Sell
11,225
-101
-0.9% -$2.25K 0.09% 212
2016
Q4
$273K Sell
11,326
-303
-3% -$8.44K 0.11% 169
2016
Q3
$323K Sell
11,629
-605
-5% -$16K 0.14% 147
2016
Q2
$298K Buy
12,234
+5,751
+89% +$163K 0.13% 152
2016
Q1
$218K Buy
+6,483
New +$204K 0.1% 188

Other funds holding PGEN

Cutter & Co Brokerage's PGEN Position: Q3 2017 in Review

Cutter & Co Brokerage sold out of Precigen (PGEN) in Q3 2017, closing a stake of 11,225 shares — an estimated $270K sold.

Cutter & Co Brokerage first reported a position in PGEN in Q1 2016 and held it in 6 quarters. The position peaked at $323K in Q3 2016. 155 funds tracked by Wall St. Rank hold PGEN as of Q3 2017.

  • Cutter & Co Brokerage reported no remaining Precigen position as of Q3 2017 after selling out during the quarter.
  • Cutter & Co Brokerage sold 11,225 Precigen shares in Q3 2017, an estimated $270K.
  • Cutter & Co Brokerage first reported a position in Precigen in Q1 2016 and held it in 6 quarters.
  • Cutter & Co Brokerage's Precigen position peaked at $323K in Q3 2016.
  • 155 funds tracked by Wall St. Rank held Precigen as of Q3 2017.

Based on Cutter & Co Brokerage's 13F filing for Q3 2017, filed 23 Oct 2017.